SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022. - Kagucia EW; Ziraba AK; Nyagwange J; Kutima B; Kimani M; Akech D; Ng'oda M; Sigilai A; Mugo D; Karanja H; Gitonga J; Karani A; et al. (Influenza and other respiratory viruses, 2023)